Momentum building for Medtech microcap Dorsavi

After a slow start post-IPO, Dorsavi has been gaining commercial momentum across all of its business divisions over the last 4 months. In particular, the company has announced signing five new OHS clients and a number of existing clients have expanded their contracts, including its largest Occupational Health & Safety (OHS) contract to date with Crown Resorts. Under the contract, DVL will use ViSafe to collect movement information from Crown's workers in both Melbourne and Perth and use those data to identify and manage activities where there is a high risk of workplace injury. This is DVL's fourth contract with Crown and planned to be implemented over 18 months. It has also just announced signing up a third NFL team, the New England Patriots, the sixth most valuable sports team in the world, and two elite university athletic programs, Ohio State University and Marquette University. We believe Dorsavi's commercial momentum is set to continue and retain our BUY recommendation and a $0.75 12-month price target. Our full research is here: (VIEW LINK)